[HTML][HTML] Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison

D Altomare, C Caprioglio, F Assal, G Allali… - European journal of …, 2021 - Springer
Purpose Assess the individual and combined diagnostic value of amyloid-PET and tau-PET
in a memory clinic population. Methods Clinical reports of 136 patients were randomly …

[HTML][HTML] Review of quantitative methods for the detection of Alzheimer's disease with positron emission tomography

J Perron, JH Ko - Applied Sciences, 2022 - mdpi.com
Featured Application A thorough review of the quantitative methods for the detection of
Alzheimer's from neuroimaging studies acquired with positron emission tomography, with a …

Towards clinical application of tau PET tracers for diagnosing dementia due to Alzheimer's disease

R Ossenkoppele, O Hansson - Alzheimer's & Dementia, 2021 - Wiley Online Library
The recent development of several tau positron emission tomography (PET) tracers
represents a major milestone for the Alzheimer's disease (AD) field. These tau PET tracers …

A review of the flortaucipir literature for positron emission tomography imaging of tau neurofibrillary tangles

SC Burnham, L Iaccarino, MJ Pontecorvo… - Brain …, 2024 - academic.oup.com
Alzheimer's disease is defined by the presence of β-amyloid plaques and neurofibrillary tau
tangles potentially preceding clinical symptoms by many years. Previously only detectable …

Deep learning improves utility of tau PET in the study of Alzheimer's disease

J Zou, D Park, A Johnson, X Feng… - Alzheimer's & …, 2021 - Wiley Online Library
Introduction Positron emission tomography (PET) imaging targeting neurofibrillary tau
tangles is increasingly used in the study of Alzheimer's disease (AD), but its utility may be …

Tau as a diagnostic instrument in clinical trials to predict amyloid in Alzheimer's disease

S Shcherbinin, A Morris, IA Higgins… - … Research & Clinical …, 2023 - Wiley Online Library
INTRODUCTION Alzheimer's disease (AD) is characterized by the presence of both amyloid
and tau pathology. In vivo diagnosis can be made with amyloid and tau positron emission …

Tau Imaging with 18F-MK6240 across the Alzheimer's Disease spectrum

CC Rowe, V Doré, N Krishnadas, S Burnham, F Lamb… - medRxiv, 2022 - medrxiv.org
Tau deposition plays a critical role over cognition and neurodegeneration in Alzheimer's
disease (AD). Recent generation tracers have high target to background ratios giving a wide …

Future directions in molecular imaging of neurodegenerative disorders

H Barthel, VL Villemagne… - Journal of Nuclear …, 2022 - Soc Nuclear Med
The improvement of existing techniques and the development of new molecular imaging
methods are an exciting and rapidly developing field in clinical care and research of …

[HTML][HTML] The clinical use of Alzheimer's disease biomarkers in patients with mild cognitive impairment: a European Alzheimer's disease Consortium survey

C Caprioglio, V Garibotto, F Jessen… - Journal of …, 2022 - content.iospress.com
Background: Recent advances occurred in the field of Alzheimer's disease (AD) biomarkers
and the introduction of a research framework grounded on a biomarker-based definition of …

Reduced cerebral blood flow of lingual gyrus associated with both cognitive impairment and gait disturbance in patients with idiopathic normal pressure …

Y Suzuki, C Iseki, R Igari, H Sato, S Koyama… - Journal of the …, 2022 - Elsevier
Background Idiopathic normal pressure hydrocephalus (iNPH) is primarily characterized by
cognitive impairment and gait disturbance. Our objective was to evaluate the clinical …